title: Prognosis of t1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas.
authors.affiliation: Institut Curie, Paris, France.
authors.forename: Luc
authors.initials: L
authors.lastname: Cabel
authors.affiliation: Centre Hospitalier de Lyon-Sud, Lyon, France.
authors.forename: Julien
authors.initials: J
authors.lastname: Péron
authors.affiliation: Institut Curie, Paris, France.
authors.forename: Paul Henri
authors.initials: PH
authors.lastname: Cottu
authors.affiliation: Institut Curie, Paris, France manuel.rodrigues@curie.fr.
authors.forename: Manuel Jorge
authors.initials: MJ
authors.lastname: Rodrigues
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000737:chemistry* / Q000188:drug therapy*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis*
chemical_list: D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases